← SynDRA

GSK-1292263

SynDRA canonical compound SYN0037961 — structure-anchored drug synonym record

All known targets

• GPR119
• GRPR

Mechanisms of action (all sources)

• GPR119 AGONIST
• Glucose-dependent insulinotropic receptor agonist
• glucose dependent insulinotropic receptor agonist

Cross-references

• PubChem CID: 24996872
• ChEMBL: CHEMBL3187503
• DrugBank: DB12627
• PDB: A1D8Y
• LINCS BRD: BRD-K60341624

Synonyms

• GSK1292263
• GSK-1292263A
• GSK-263A
• GSK 1292263
• 3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
• 5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole
• R1J57STA6O
• 5-(((1-(3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl)-4-piperidinyl)methyl)oxy)-2-(4-(methylsulfonyl)phenyl)pyridine
• GPR119 receptor agonist GS1292263
• Pyridine, 5-((1-(3-(1-methylethyl)-1,2,4-oxadiazol-5-yl)-4-piperidinyl)methoxy)-2-(4-(methylsulfonyl)phenyl)-
• 5-[[[1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl]methyl]oxy]-2-[4-(methylsulfonyl)phenyl]pyridine
• UNII-R1J57STA6O
• 5-[({1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine
• GSK1292263A
• 5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazo
• MLS006011146
• SCHEMBL387238
• CHEMBL3187503
• EX-A042
• DTXSID501025666
• HMS3655D04
• AMY24151
• BCP02375
• BDBM50463649
• MFCD18385004
• s2149
• ZINC68208690
• AKOS016011432
• BCP9000735
• CCG-269300
• CS-0228
• DB12627
• EX-7217
• GSK 1292263 [WHO-DD]
• SB16859
• NCGC00346568-01
• NCGC00346568-02
• NCGC00346568-05